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 2 
ABSTRACT 2 
Objectives 
This study aimed to (i) compare the volumes of vastus medialis, vastus lateralis, vastus 4 
intermedius and rectus femoris and the ratio of vastus medialis and vastus lateralis (VM/VL) 
volumes between asymptomatic controls and patellofemoral joint osteoarthritis (PFJ OA) 6 
participants; and (ii) assess the relationships between cross-sectional area (CSA) and volumes 
of the vastus medialis and vastus lateralis in individuals with and without PFJ OA. 8 
 
Methods 10 
Twenty-two participants with PFJ OA and 11 controls aged ≥ 40 yrs were recruited from the 
community and practitioner referrals. Muscle volumes of individual quadriceps components 12 
were measured from thigh magnetic resonance (MR) images. The CSA of the vastus medialis 
and lateralis were measured at 10 equally distributed levels (femoral condyles to lesser 14 
femoral trochanter).  
 16 
Results 
PFJ OA individuals had smaller normalized vastus medialis (mean difference 0.90 cm3.kg-1, 18 
α=0.011), vastus lateralis (1.50 cm3.kg-1, α=0.012) and rectus femoris (0.71 cm3.kg-1, 
α=0.009) volumes than controls. No differences in the VM/VL ratio were observed. The CSA 20 
at the 3rd level (controls) and 4th level (PFJ OA) above the femoral condyles best predicted 
vastus medialis volume, whereas the vastus lateralis volume was best predicted by the CSA at 22 
the 7th level (controls) and 6th level (PFJ OA) above the femoral condyles. 
 24 
Conclusion 
 3 
Reduced quadriceps muscle volume was a feature of PFJ OA. Muscle volume could be 2 
predicted from CSA measurements at specific levels in PFJ OA patients and controls. 
 4 
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 4 
INTRODUCTION 2 
The patellofemoral joint (PFJ) is the compartment most commonly affected in symptomatic 
knee osteoarthritis (OA)1 and is the dominant source of symptoms associated with knee 4 
OA2,3.Contemporary clinical guidelines recommend tailored OA management strategies to 
optimize clinical outcomes, yet there is little known about modifiable impairments that could 6 
guide effective management of PFJ OA. Quadriceps weakness plays an important role in the 
pathogenesis of knee OA4 and appears to be more important in the progression of PFJ disease 8 
than tibiofemoral joint (TFJ) disease5. Dynamometry provides an indication of the force 
produced by the entire quadriceps; however, the limitations of this technique include an 10 
inability to evaluate contributions of the individual quadriceps subregions. This may be 
important for PFJ OA, since imbalance of the medial (vastus medialis) and lateral (vastus 12 
lateralis) quadriceps force may affect PFJ alignment6 and hence PFJ contact pressure7. 
Considering that increased PFJ contact pressure is likely to be associated with the initiation 14 
and progression of PFJ OA, an imbalance in the force generating capacity of the medial and 
lateral vasti in people with PFJ OA may be a potentially modifiable factor associated with the 16 
development or progression of PFJ OA.  
 18 
Magnetic resonance (MR) imaging is one technique that is capable of evaluating the force 
generating capacity of the individual vasti components. While measurement of muscle cross-20 
sectional area (CSA) from MR imaging is gaining popularity as a surrogate measure of 
individual vasti muscle strength8-10, more meaningful information may be obtained from 22 
measures of muscle volume. A muscle’s force generating capacity, sometimes also referred 
to as peak isometric muscle strength or peak isometric force11, is related to its volume and its 24 
physiological cross sectional area (PCSA)12. However, prior studies8-10 obtained anatomical 
CSAs of muscles at various levels that may not be representative of the muscles’ PCSAs. In a 26 
 5 
pennate muscle, the anatomical CSA does not account for angle of muscle pennation or 2 
muscle fiber length and hence, may not be a true representative of muscle force. The CSA 
level of a muscle that has a strong correlation with the muscle’s volume should provide an 4 
indication of the muscle’s strength. The CSA at this level would provide a measurement that 
could be used to estimate peak isometric muscle force, and would negate the necessity to 6 
measure the entire muscle volume using MR, which can be expensive and time consuming. 
 8 
The present study aimed to (i) compare the volumes of the individual quadriceps components 
(vastus medialis, vastus lateralis, vastus intermedius and rectus femoris) and the ratio of 10 
vastus medialis and vastus lateralis (VM/VL) volumes between controls and PFJ OA 
participants; and (ii) assess the relationships between CSA and volumes of the vastus 12 
medialis and vastus lateralis in individuals with and without PFJ OA. 
 14 
MATERIALS AND METHODS 
Participants 16 
Twenty-two participants with PFJ OA (symptomatic and radiographic) and 11 controls 
(asymptomatic and no radiographic OA) ≥ 40 years of age were recruited for the study. The 18 
PFJ OA eligibility criteria were based on a previous study protocol13. Patients were included 
if they exhibited clinical symptoms arising from the PFJ (anterior or retropatellar knee pain 20 
severity ≥ 4 on an 11-point numerical pain scale during ≥ two PFJ loading activities: stair 
ambulation, squatting and rising from sitting; aggravating activities, symptoms present on 22 
most days during the past month) and radiographic criteria (Kellgren and Lawrence (KL) 
grading14 applied to the lateral PFJ ≥ 2 from skyline views3. While the PFJ OA patients may 24 
have exhibited TFJ OA, PFJ OA patients were excluded if they exhibited a KL grading ≥ 2 
from postero-anterior views in order to eliminate those with moderate-severe TFJ OA and 26 
 6 
hence limit our cohort to those with predominant PFJ OA. The control participants had no 2 
lower limb complaints, were physically active and had no radiographic OA (KL grade 0 in all 
compartments). Exclusion criteria for all participants included major surgery (including 4 
arthroplasty or osteotomy, but not arthroscopy); knee injections (within 3 months); current or 
previous physiotherapy for knee pain (within 12 months); planned lower limb surgery 6 
(following 6 months); history of hip or knee fractures; current conditions affecting the ability 
to walk normally; concomitant pain from other knee structures, hips, ankles, feet or lumbar 8 
spine; neurological or medical conditions; fibromyalgia; and contraindications for MR. Ethics 
approval for the study was obtained from the University of Melbourne Human Research 10 
Ethics Committee and the Department of Human Services Victoria Radiation Safety 
committee. All participants provided written informed consent. Age, gender, height, body 12 
weight and body mass index (BMI) were recorded for all subjects. The pain subscale of the 
Knee Injury and Osteoarthritis Outcome Score (KOOS-pain) was used to score knee 14 
osteoarthritis pain15.  
 16 
Measurement of quadriceps volume 
MR imaging was performed in the supine position on the most symptomatic leg in the PFJ 18 
OA group and the dominant leg in the control group. Both knees were fully extended to 
ensure uniformity of positioning between subjects. The MR images were recorded on a 20 
Siemens (Erlangen Germany) 3T Trio MR scanner using a T2-weighted fat-suppressed 
(water excitation) MEDIC (multi-echo data image combination) gradient echo sequence (TE 22 
= 12 ms, TR = 23 ms, NEX = 1, Flip angle 12 degrees, 155Hz/Px, Parallel imaging GRAPPA 
2) with a slice thickness of 1 mm isotropic voxels. This sequence was chosen because it was 24 
fast and gave reasonable delineation of muscle, cartilage and bone. The in-plane image 
resolution was 397 x 916 pixels. The number of coronal images ranged from 300 to 400 for 26 
 7 
each participant depending on their height. Acquisition time was approximately 25 minutes 2 
per subject. 
 4 
The CSAs of the vastus medialis, vastus lateralis, vastus intermedius and rectus femoris 
muscles were measured on axial MR images from the origin of the muscle to the insertion by 6 
manually digitizing muscle boundaries using commercially available software (Amira 5.2, 
Visage Imaging, Berlin). For each muscle, the CSAs of each axial slice were summed and the 8 
total sum of the muscle CSAs was then multiplied by the slice thickness to obtain the muscle 
volume (Fig 1A). For each participant, the CSAs of the vastus medialis and vastus lateralis 10 
were recorded at ten evenly spaced levels from the femoral condyles through to the lesser 
trochanter (Fig 1B). 12 
 
 14 
 
 16 
The intra-rater reliability of the muscle volume measurement technique was quantified in 
nine randomly selected subjects (5 PFJ OA; 4 controls). The reliability coefficients obtained 18 
for vastus lateralis (ICC=0.998; 95% CI: 0.991 to 1.00), vastus medialis (ICC=0.998; 95% 
CI: 0.991 to 1.00), vastus intermedius (ICC=0.997; 95% CI: 0.987 to 0.999) and rectus 20 
femoris (ICC=0.994; 95% CI: 0.975 to 0.999) indicate excellent repeatability of the 
measures. Accordingly, the standard error of measurement (SEM) was acceptably low (vastus 22 
lateralis 0.10 cm3.kg-1; vastus medialis 0.06 cm3.kg-1; vastus intermedius 0.14 cm3.kg-1; rectus 
femoris 0.05 cm3.kg-1).  24 
 
Statistical analysis 26 
 8 
All data were analyzed with the Statistical Package for the Social Sciences (PASW Statistics 2 
18, SPSS Inc., Chicago, IL) and α < 0.05. Between-group differences in participant 
characteristics were assessed using independent t-tests or chi square tests as appropriate. The 4 
ratio of vastus medialis to vastus lateralis (VM/VL) muscle volume was calculated for both 
the control and PFJ OA groups. To control for the influence of body weight and gender, 6 
muscle volumes (cm3.kg-1) were normalized to body weight and all between-group 
comparisons of muscle volumes were performed using an Analysis of Covariance (with and 8 
without gender as a covariate). Radiographic disease severity and knee pain are also potential 
confounders, and the univariate association of radiographic disease severity of the PFJ 10 
(measured with the KL grading system14) and the KOOS-pain subscale with the individual 
muscle volumes was determined using the Spearman’s rho correlation coefficient. Regression 12 
analyses were performed on the ten equally-spaced CSAs (from the femoral condyles to 
lesser trochanter of the femur) of vastus medialis and vastus lateralis to determine the CSA 14 
that best predicted the muscle volume in the control and PFJ OA groups. To evaluate whether 
dominance influenced vasti muscle size, the CSA that best represented the medial and lateral 16 
vasti was also calculated for the non-dominant leg of the control group, and these were 
compared to the dominant leg using a paired t-test. 18 
 
RESULTS 20 
Participant and disease characteristics 
The control group (n = 11; age 53 ± 5 years, body weight 71 ± 14 kg, BMI 25 ± 3 kg.m-2) and 22 
the PFJ OA group (n = 22; age 57 ± 11 years, weight 77 ± 13 kg, BMI 27 ± 4 kg.m-2) were 
matched for all participant characteristics (p > 0.05). There were more females than males in 24 
both groups (female: male ratios in the control and PFJ OA groups were 7:4 and 15:7, 
respectively), with no difference in the frequencies (χ² = 0.546; p-value = 0.07). No 26 
 9 
association was observed between muscle volumes and PFJ radiographic disease severity 2 
(vastus medialis: rs = -0.291; p = 0.189; vastus lateralis: rs = -0.156; p = 0.487; VM/VL ratio: 
rs = -0.202; p = 0.367), or KOOS-pain (vastus medialis: rs = -0.135; p = 0.550; vastus 4 
lateralis: rs = -0.119; p = 0.598; VM/VL ratio: rs = 0.212; p = 0.344). 
 6 
Between-group comparison of quadriceps volume 
Individuals with PFJ OA had smaller normalized muscle volumes of vastus medialis (mean 8 
difference 0.90 cm3.kg-1, 95% confidence interval [0.22 to 1.57]; α = 0.011), vastus lateralis 
(1.50 cm3.kg-1, [0.35 to 2.64]; α = 0.012), and rectus femoris (0.71 cm3.kg-1, [0.19 to 1.22; α 10 
= 0.009) than controls (Table 1). No differences were observed in vastus intermedius (0.56 
cm3.kg-1, [-0.59 to 1.71]; α = 0.331). These results were reflected in peak isometric muscle 12 
strength comparisons (see Supplementary Material). The ratio of VM/VL muscle volumes in 
the PFJ OA group (0.66 ± 0.08) and the control group (0.64 ± 0.06) were not different (0.27, 14 
[-0.50; 1.05]; α = 0.47).  
 16 
Relationship between vastus medialis and lateralis volumes and cross-sectional areas 
For the vastus medialis, regression modeling revealed that the CSA at the 3rd level (r2 = 18 
0.936; B = 17; α < 0.001) and 4th level above the femoral condyles (r2 = 0.668; B = 18; α < 
0.001) were the best predictors of muscle volume in the controls and PFJ OA participants, 20 
respectively. For the vastus lateralis, muscle volume was predicted by the CSA at the 7th level 
above the femoral condyles (r2 = 0.916; B = 26; α < 0.001) in the controls, and at the 6th level 22 
above the femoral condyles (r2 = 0.705; B = 17; α < 0.001) in the PFJ OA participants. These 
levels generally represented the largest CSA for each muscle.  24 
 
Comparison of muscle size between dominant and non-dominant limbs 26 
 10 
For the vastus medialis, the CSA at the 3rd level of the dominant leg (20 ± 6 cm2) was not 2 
significantly different from the non-dominant leg (21 ± 7 cm2); p = 0.161. Similarly, for the 
vastus lateralis there was no significant difference between the CSA at the 7th level for the 4 
dominant leg (28 ± 5 cm2) and the non-dominant leg (27 ± 6 cm2); p = 0.184. 
 6 
DISCUSSION 
The volumes of the vastus medialis and vastus lateralis, normalized to body weight, were 8 
significantly smaller in the PFJ OA group (approximately 20%) than the control group. 
However, we found no difference in the ratio of VM/VL volumes between those with and 10 
without PFJ OA. In both the PFJ OA and the control group, the ratio of VM/VL was 
approximately 0.67, indicating that the vastus medialis volume was approximately 2/3 that of 12 
the vastus lateralis in both groups. Based on the evidence from cadaveric and modeling 
studies, indicating that imbalance of the medial and lateral vasti contributes to heightened 14 
lateral PFJ stress16,17, we considered that there may have been a lower ratio of VM/VL 
volumes in those with PFJ OA. Our finding of no difference in the VM/VL ratio implies that 16 
the force generating capacity of the vastus medialis is not affected to a greater extent than 
that of the vastus lateralis in our population with PFJ OA.  18 
 
While we did not observe between-group differences in the relative muscle volume between 20 
the two heads of the vasti, it is possible that altered coordination and activation of the vastus 
medialis and lateralis may exist in those with PFJ OA. Indeed, modeling studies have 22 
identified that delayed activation of the medial quadriceps (relative to the lateral quadriceps) 
increases lateral patellar malalignment18,19, leading to areas of heightened contact pressure 24 
across the lateral PFJ16,17. However, it is also possible that our findings may be more aligned 
with studies that did not observe differences in the onset timing of the medial and lateral vasti 26 
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between those with and without generalized knee OA20-22. While the current study cannot be 2 
compared to those studies that have investigated temporal aspects of the vasti activations in 
people with generalized knee OA, further investigation is required to establish whether the 4 
imbalances in activations of the vasti muscles, observed in younger people with 
patellofemoral pain23,24, are also a feature of PFJ OA.  6 
 
The finding of lower size in three of the four quadriceps in the PFJ OA group reflects 8 
previous reports of association between reduced quadriceps strength and PFJ OA5,25. Muscle 
weakness is influenced by muscle atrophy and the capacity to fully activate the muscle4. 10 
Hence, our findings suggest that vastus medialis, vastus lateralis and rectus femoris atrophy 
may be a feature of PFJ OA and likely contribute to torque deficits observed in these 12 
individuals. Smaller quadriceps muscles may have reduced capacity to absorb shock26 or 
provide integrated sensorimotor function to the knee joint27, thus rendering the joint more 14 
susceptible to damage28. Furthermore, results from a longitudinal cohort study5 and an animal 
model28 indicate that the PFJ is more susceptible to joint degeneration than the TFJ in the 16 
presence of lower quadriceps strength. Due to the cross-sectional nature of our research 
design it is not possible to determine whether the pain and structural changes associated with 18 
PFJ OA leads to muscle disuse and atrophy, or whether reduced muscle activity contributes 
to PFJ OA onset. However, our findings indicate that a program designed to improve strength 20 
in the vastus medialis and vastus lateralis, in addition to the rectus femoris, may benefit those 
with PFJ OA. However, such programs could also overload the PFJ29, with potential to 22 
increase pain; thus, progression of load should be carefully managed. Further studies are 
required to confirm whether quadriceps strengthening could reduce symptoms or disease 24 
progression in people with PFJ OA.  
 26 
 12 
We used MR imaging to quantify muscle size, which expanded on previous studies that 2 
evaluated the strength of the quadriceps when represented as one whole muscle-tendon unit. 
Since our study did not detect any imbalance in the relative contributions of the medial and 4 
lateral vasti, it is not clear whether measurement of the sizes of the individual quadriceps 
subregions provides greater value than overall quadriceps strength measures obtained from 6 
dynamometry. Furthermore, MR imaging of the entire thigh is expensive and the segmenting 
of muscle volumes is time-consuming. However, dynamometry is not readily available in the 8 
clinical setting, and this instrumentation is expensive to purchase. Our results indicate that 
CSAs of the VM and VL (at specified levels) may provide a valid indication of muscle size 10 
for those clinicians and researchers without access to dynamometry. 
 12 
Our study highlights that the VM CSA at approximately 8 cm (control) and 12 cm (PFJ OA) 
above the femoral condyles were the best predictors of VM volume, while VL CSA at 14 
approximately 24 cm (control) and 20 cm (PFJ OA) best predicted VL volume. The gross 
anatomies of the two muscles are quite distinct, which was reflected in the disparate levels 16 
that best represent the corresponding muscle volume. Indeed, these levels generally represent 
the largest CSA for each individual vastus. However, previous studies have described vasti 18 
CSA at a single level, with distances ranging from 3.8 cm8,9 to 15 cm10 superior to the 
proximal patella pole, which may not represent the muscle volumes and force capacities of 20 
these muscles. These studies ought to consider the specific CSA of the muscle that is most 
representative of the muscle’s volume, in addition to controlling for the effects of gender and 22 
body weight. 
 24 
In the current study, we investigated muscle size for the individual quadriceps components in 
people with and without symptomatic radiographic PFJ OA. The quantification of muscle 26 
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volume used in the current study provides a better estimate of the force generating capacity of 2 
the muscles than measuring anatomical CSAs, which may not be representative of the 
muscle’s PCSA. Our calculations of muscle volume, PCSA and peak isometric force values 4 
in the control group (Table 1 and Supplementary Table) were in reasonable agreement with 
those in the literature30-32. For example, our average muscle volume and PCSA of the controls 6 
for vastus lateralis (505.1 cm3 and 80.7 cm2, respectively) were of similar magnitudes to 
those of Friedrich and Brand (1990) (514.0 cm3 and 64.4 cm2, respectively)31, while our 8 
average muscle volume and PCSA of rectus femoris (206.7 cm3 and 32.9 cm2, respectively) 
compare favorably to data reported by Klein Horsman et al. (2007) (226.3 cm3 and 28.9 cm2, 10 
respectively)30.  
 12 
There are a number of limitations of our study that should be considered. The MR images 
were performed under non-weight bearing conditions at full knee extension, which is 14 
standard protocol for clinical imaging of the knee; however, it is not known whether the 
results would have been the same if a weight-bearing activity (involving quadriceps 16 
activation) was simulated. While these limitations may have influenced the calculations of 
muscle volume, they are unlikely to have affected the between-group comparisons. The use 18 
of the dominant leg to calculate muscle volume in the control group and the most 
symptomatic leg in the PFJ OA may have resulted in bias. However, we performed some 20 
preliminary analyses to confirm that the CSA for vastus medialis and vastus lateralis were not 
different between legs in the control group. Therefore, it is unlikely that meaningful between-22 
leg differences in the control group would have affected our between-group comparisons. A 
further limitation is the lack of detailed MR data, from which to score additional features of 24 
osteoarthritis. For example, the radiographs cannot reveal features such as cartilage or bone 
marrow lesions, synovitis or effusion. Therefore, we cannot rule out that some participants in 26 
 14 
the control group may have had signs of OA that were not detectable on radiographs. 2 
However, currently radiographic definitions of OA remain the gold standard, and we can be 
confident that our control group was free of radiographically detected OA.  4 
 
It is also acknowledged that neuromuscular factors contribute to a muscle’s strength and that 6 
the strength and size of other antagonistic or synergistic muscles also influence the load on 
the PF joint, and therefore may be important for people with PFJ OA. Finally, the cross-8 
sectional nature of the study design precludes any conclusions regarding the temporal 
relationship between muscle size and PFJ OA. Longitudinal studies are required to ascertain 10 
the role of quadriceps muscle size in the etiology and progression of PFJ OA. 
 12 
CONCLUSION 
There was no difference in the ratio of VM/VL volumes between those with and without PFJ 14 
OA. The volumes of the vastus medialis, vastus lateralis and rectus femoris, normalized to 
body weight, were approximately 20% smaller in the PFJ OA than the control group. Further 16 
studies are required to ascertain whether imbalance in the activations of the vastus medialis 
and lateralis is a feature of PFJ OA, and whether quadriceps strengthening can reduce 18 
symptoms or disease progression in people with PFJ OA. 
 15 
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FIGURE CAPTIONS 
 
Fig 1:  (A) Delineation of the vastus medialis (yellow), vastus lateralis (green), vastus 
intermedius (orange) and rectus femoris (purple) on axial MR images, where i) 
represents segmented and unsegmented proximal axial MR image, ii) represents 
segmented and unsegmented mid thigh axial MR image and iii) represents segmented 
and unsegmented distal axial MR image. (B) Cross-sectional areas of the vastus 
medialis and vastus lateralis were obtained at ten evenly spaced levels from the 
femoral condyles to the lesser trochanter of the femur (dashed lines). The solid black 
lines identify the levels that were the strongest predictors of muscle volume for the 
controls, whereas the solid gray lines identify the levels that were the strongest 
predictors of muscle volume for the PFJ OA participants. 
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FIGURES  Figure 1 
(Separate file attachment) 
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TABLES 
Table 1:  Averaged muscle volumes of the quadriceps for the PFJ OA and control groups. Muscle volume and muscle volume normalized to 
subject mass are given, along with standard deviations (SD). Significant differences (p<0.05) in normalized muscle volume between 
the PFJOA subjects and control subjects are indicated.  
                     
Muscle
PFJOA 453.1 (173.2) 5.8 (1.6)
Control 505.1 (202.7) 7.3 (1.4)
PFJOA 292.9 (100.9) 3.7 (0.9)
Control 325.2 (129.3) 4.6 (0.9)
PFJOA 397.4 (173.7) 5.0 (1.6)
Control 418.3 (191.4) 5.6 (1.3)
PFJOA 177.9 (71.3) 2.3 (0.7)
Control 206.7 (81.1) 3.0 (0.7)
 (cm3)
Muscle volume (SD)
(cm3/kg)
Normalized muscle 
volume (SD)
Vastus lateralis
Vastus medialis
Vastus intermedius
Rectus femoris
p = 0.012
p = 0.009
p = 0.011
